Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
They can help investors narrow down which stocks are better for their portfolio and which ones can beat the market over the long-term. Growth investors build their portfolios around companies that are financially strong and have a bright future. The Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth. United Therapeutics Corporation is a company based in Silver Spring, MD, that markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, Orenitram, Tyvaso, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets. United Therapeutics Corporation boasts a Growth Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Its bottom-line is projected to rise 27.3% year-over-year for 2024, while Wall Street anticipates its top line to improve by 23.4%. Investors should take the tim
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- The AI Moguls, Crypto Kingpins And Celebrities Who Became Billionaires In 2024 [Forbes]Forbes
- Here are Updates on United Therapeutics Corp. (UTHR) [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Patients are so sick and tired of waiting years for a transplant that they're signing up in droves to receive vital organs from pigs [Fortune]Fortune
- Gene-Edited Pig Kidney Gives Living Donor New Lease on Life [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 10/30/24 - Beat
UTHR
Sec Filings
- 12/20/24 - Form 4
- 12/19/24 - Form 4
- 12/18/24 - Form 144
- UTHR's page on the SEC website